Neuberger Berman Group LLC Bristol Myers Squibb CO Transaction History
Neuberger Berman Group LLC
- $114 Billion
- Q1 2025
A detailed history of Neuberger Berman Group LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Neuberger Berman Group LLC holds 4,517,754 shares of BMY stock, worth $218 Million. This represents 0.24% of its overall portfolio holdings.
Number of Shares
4,517,754
Previous 2,650,872
70.43%
Holding current value
$218 Million
Previous $150 Million
83.77%
% of portfolio
0.24%
Previous 0.12%
Shares
34 transactions
Others Institutions Holding BMY
# of Institutions
2,809Shares Held
1.59BCall Options Held
25.9MPut Options Held
23.9M-
Vanguard Group Inc Valley Forge, PA191MShares$9.24 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.66 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.22 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.58 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.21 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $103B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...